| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7664001 | Revue Francophone des Laboratoires | 2008 | 5 Pages |
Abstract
Neuroendocrine large cell carcinoma of the lung is a rare tumor, identified by the WHO in 1999 whose histological diagnosis remains difficult. Diagnostic criteria as well as phenotypical and molecular characteristics are specified. Main differential diagnoses involve small cell carcinoma and sometimes the other subtypes of non small cell lung carcinoma. The overall prognosis is bad, close to the ones observed in small cell carcinoma. Treatment of this entity remains controversial, with an approach often close to the small cell carcinoma, but the role of adjuvant therapy should be evaluated in large prospective randomized trials.
Related Topics
Physical Sciences and Engineering
Chemistry
Analytical Chemistry
Authors
Marie-Christine Charpentier, Marwan Qubaja, Agnès Le Tourneau, Jacques Diebold, Josée Audouin, Thierry Molina,